Search

636 Result(s)
Sort by

Annual Results Press Conference

Annual Results Press Conference

Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Pet parasites are still here. What's the risk?

Pet parasites are still here. What's the risk?

What's the risk of pet parasites? They’re a growing challenge due to climate change. Check how to protect your dog and cat from fleas, ticks and more.
More Than Scleroderma

More Than Scleroderma

A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Hidradenitis suppurativa

Hidradenitis suppurativa

Find out more about hidradenitis suppurativa (HS), a long-term, inflammatory, recurrent, skin disease
ACR19 Autoimmune Trial

ACR19 Autoimmune Trial

ACR Congress 2019 abstract analysing a subgroup of patients with autoimmune diseases in the INBUILD® trial of nintedanib in patients with PF-ILF
Living with type 2 diabetes

Living with type 2 diabetes

People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.
Respiratory

Respiratory

Human Pharma Clinical Pipeline Respiratory therapeutic area
More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Immunology

Immunology

Human Pharma Clinical Pipeline Immunology therapeutic area
Making more health through animal health

Making more health through animal health

Boehringer Ingelheim and Ashoka aim to build a world with a greater access to health for people, animals and their communities.
Life stages of cats

Life stages of cats

Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.
Kicking off 2024 with five new R&D partnerships

Kicking off 2024 with five new R&D partnerships

We are kicking off 2024 with five new R&D partnerships to further enable and accelerate the company’s commitment to transform the lives of patients world-wide.